Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4EVERLUNG: Everolimus in Lung Transplant
NCT01404325Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in lung transplantation, sponsored by Novartis. Started Feb 2012; status: completed.
02
Drugs
everolimus
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NCT01404325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404325.